Your session is about to expire
← Back to Search
[18F]APN-1607 PET Imaging for Alzheimer's Disease
Study Summary
This trial is testing a new imaging technique to see if it can better detect Alzheimer's disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman who cannot become pregnant or will not be pregnant during the study.I am between 50 and 85 years old.I am a male and will use two forms of birth control, including a condom, or abstain from sex during the study.My immediate family has no history of early-onset Alzheimer's or similar diseases before 65.I am in good health with no significant issues found in my recent medical checks.I will not donate sperm during the study.
- Group 1: [18F]APN-1607
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many research participants are involved in this clinical trial?
"Affirmative. Clinicaltrials.gov records indicate that this clinical trial, which was first publicly posted on 19 August 2019, is currently recruiting participants. Precisely 130 individuals must be found from 1 centre of care to complete the study."
Are there any vacancies available for participants in this research project?
"According to information available on clinicaltrials.gov, this medical research is currently open for enrollment. It was initially listed on August 19th 2019 and has been updated as recently as April 22nd 2022."
Does participation in this trial extend to geriatric patients?
"This research necessitates that patients must be aged 50 to 85. Unfortunately, there are not a plethora of medical trials for those under 18 or over 65; only 94 and 1294 respective studies were found respectively."
Is [18F]APN-1607 a viable option for patients with minimal risk?
"Our assessment of [18F]APN-1607's safety comes in at a 2, since this is still an experimental phase and there has only been data to support its safety but not efficacy."
To whom is this clinical trial open for participation?
"This clinical trial aims to recruit 130 people with Alzheimer's between the ages of 50 and 85. Eligible patients must meet certain requirements, including: Females who are medically documented as surgically sterile or post-menopausal for at least one year, those of childbearing potential agreeing to use a barrier contraception method or abstain from sexual intercourse during the study period in addition to having a negative pregnancy test; willing and able to participate in all procedures; clinically healthy results on physical examination, laboratory profiles, Vital Signs (VS), Electrocardiogram (ECG) at screening and imaging visit; have a Clinical Dementia Rating score of 0"
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger